STOCK TITAN

LifeVantage Receives U.S. Patent for Healthy Glow Essentials Stack

(Positive)
Tags

LifeVantage (Nasdaq: LFVN) received U.S. Patent No. 12,589,067 B2 (issued March 31, 2026) for its Healthy Glow Essentials Stack, covering compositions and methods pairing Protandim Nrf2 Synergizer and TrueScience Liquid Collagen.

The patent cites synergistic activation of cellular signaling genes and fibroblast study results supporting skin benefits and broader cellular-health effects, reflecting over three years of the company’s R&D work.

Loading...
Loading translation...

Positive

  • U.S. patent granted (No. 12,589,067 B2) on March 31, 2026
  • Patent covers composition and methods for Healthy Glow Essentials Stack activator pairing
  • R&D validation: over three years of research cited by company

Negative

  • Not FDA evaluated: product statements have not been evaluated by the Food and Drug Administration
  • No commercial or financial impact metrics disclosed in the announcement

News Market Reaction – LFVN

-4.29%
6 alerts
-4.29% Session close to close
+2.2% Peak Tracked
-10.0% Trough Tracked
$70.07M Market Cap
1.4x Rel. Volume

In the Apr 21 session, LFVN declined 4.29%, reflecting a moderate negative market reaction. Argus tracked a peak move of +2.2% during that session. Argus tracked a trough of -10.0% from its starting point during tracking. Our momentum scanner triggered 6 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement adds a granted U.S. patent for the Healthy Glow Essentials Stack™, supporting Life...
Analysis

This announcement adds a granted U.S. patent for the Healthy Glow Essentials Stack™, supporting LifeVantage’s science‑driven positioning in nutrigenomics. Recent news has centered on leadership transition, international expansion and investor conference participation, each accompanied by modestly positive price reactions. Investors may watch how this patent influences product traction over time, while also tracking any use of the effective $75.0 million shelf registration and ongoing management changes.

Key Figures

Shelf registration size: $75.0 million Current share price: $5.13 Last reported price: $4.91 +5 more
8 metrics
Shelf registration size $75.0 million S-3 shelf filed 2026-03-10
Current share price $5.13 Price at latest close before patent news
Last reported price $4.91 Cited in S-3 prospectus on March 4, 2026
Shares outstanding 12,804,772 Common shares as of March 4, 2026
Non‑affiliate market value $65,580,155 Common stock held by non‑affiliates as of Feb 26, 2026
Patent number 12,589,067 B2 U.S. patent for Healthy Glow Essentials Stack
Patent issue date March 31, 2026 Grant date for Healthy Glow Essentials Stack patent
R&D duration Over three years Research and development for Healthy Glow Essentials Stack

Historical Context

5 past events · Latest: Apr 20 (Positive)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Apr 20 Corporate event updates Positive +7.3% Momentum Academy event, new AXIO flavors, patent mention and CEO transition.
Apr 16 Leadership change news Positive +4.6% Announcement of incoming CEO Terrence Moorehead and CEO transition timing.
Apr 09 Conference participation Neutral +3.2% Participation in Water Tower Research Insights Conference with management presentation.
Apr 02 Geographic expansion Positive +1.2% Planned May 2026 Portugal market launch for key nutrigenomic products.
Mar 16 Investor conference Neutral +0.8% Sidoti Small Cap Conference participation with webcasted management presentation.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent company news over the last month has consistently coincided with positive single‑day price reactions, suggesting investors have been rewarding announcements on leadership, events and market expansion.

Recent Company History

Over the past month, LifeVantage has reported several corporate and growth developments. An event-focused update on Apr 20 highlighted product launches, a patent mention and leadership changes, with a 7.32% gain. Prior news on Apr 16 announcing a new CEO saw a 4.6% move, while conference participation on Apr 9 and Mar 16 produced smaller gains. Expansion into Portugal on Apr 2 also aligned with a positive reaction. Today’s granted patent further extends this momentum in innovation-focused headlines.

Key Terms

nutrigenomics, cellular signaling genes, oxidative stress, GLP-1, +1 more
5 terms
nutrigenomics medical
"a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds"
Nutrigenomics is the study of how the foods and nutrients we eat interact with our genes to influence health, weight, and disease risk. Think of genes as an instruction manual and food as the tools that can change how those instructions work; differences in diet can turn certain genetic tendencies on or off. Investors watch nutrigenomics because it drives demand for personalized diets, genomic testing, tailored supplements and related technologies, creating new markets and business models in healthcare, food and wellness.
cellular signaling genes medical
"for nutritional supplement composition and methods for activating cellular signaling genes"
Cellular signaling genes are the instructions cells use to send, receive and process messages that control growth, defenses and other behaviors; think of them as the wiring and traffic lights that keep a city’s activity coordinated. Investors care because changes or drugs that target these genes can alter disease progression, create new therapies or diagnostics, and therefore affect a biotech company's prospects, regulatory risk and potential market value.
oxidative stress medical
"a pet supplement formulated to combat oxidative stress in dogs."
Oxidative stress is a biological imbalance where damaging, unstable molecules overwhelm the body’s neutralizing defenses, similar to how rust forms when metal is exposed to oxygen and moisture. Investors should care because oxidative stress is linked to many diseases and aging processes, influencing demand for drugs, diagnostics, supplements, and healthcare spending, and it can affect the commercial value and regulatory outlook of related products.
GLP-1 medical
"MindBody GLP-1 System™, and the comprehensive gut activator, P84"
GLP-1 (glucagon-like peptide-1) is a natural hormone in the body that helps regulate blood sugar levels and appetite. Its significance to investors lies in its role as the basis for a class of medications that address conditions like type 2 diabetes and obesity, which are large and growing markets. Advances or investments in GLP-1-based treatments can signal opportunities in healthcare innovation and potentially impact pharmaceutical companies’ growth.
nootropic medical
"as well as AXIO® nootropic energy drink mixes, the full TrueScience® line"
A nootropic is a drug, supplement or compound sold with the claim that it improves thinking skills such as memory, focus, creativity or mental energy. For investors it matters because demand, scientific evidence, safety and regulatory approval determine whether products actually sell and sustain profits—think of a nootropic like a software update promising faster performance: if the upgrade works and is allowed, the maker can gain market share; if it fails or is restricted, value can fall.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Expands intellectual property portfolio and underscores commitment to science-backed health and wellness solutions

SALT LAKE CITY, April 21, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced it has been granted a United States Patent No. 12,589,067 B2, issued March 31, 2026, for nutritional supplement composition and methods for activating cellular signaling genes of its Healthy Glow Essentials Stack™ which contains key activators Protandim® Nrf2 Synergizer® and TrueScience®Liquid Collagen.*  

According to the patent, compositions of the product duo improved the skin and impacted key regulatory genes associated with several important cellular pathways. Protandim® Nrf2 Synergizer® supports the body’s own production of powerful antioxidants to fight the signs of aging, while TrueScience® Liquid Collagen helps activate, replenish, and maintain the body’s natural collagen—supporting smoother skin, hydration, and overall health for hair, joints, and connective tissue.*

Studies in fibroblasts show that together they synergistically activate the body's natural ability to break the cellular stress cycle that can accelerate signs of aging.  Getting to the root of heightened stress at the cellular level makes a significant impact on your health, helping to deliver skin benefits, and supporting various functions and systems throughout the body, such as joint health, cardiovascular function, and gut health.*

"Receiving this U.S. patent for Healthy Glow Essentials Stack™ is the culmination of over three years of rigorous research and development," said Lisa Barnes, LifeVantage Vice President of Research and Development. "Our team discovered powerful synergies through systematic testing of Activator pairings. This patent further validates our science-driven approach and reinforces LifeVantage's position as an innovation leader in the industry."

For more information about LifeVantage and to shop its products, visit www.LifeVantage.com.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.


About LifeVantage Corporation

LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, MindBody GLP-1 System™, and the comprehensive gut activator, P84, and activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System®, as well as AXIO® nootropic energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.

Investor Relations Contact:
Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com


FAQ

What did LifeVantage (LFVN) patent on March 31, 2026?

LifeVantage was granted U.S. Patent No. 12,589,067 B2 for the Healthy Glow Essentials Stack composition and methods. According to the company, the patent covers pairings of Protandim Nrf2 Synergizer and TrueScience Liquid Collagen that synergistically activate cellular signaling genes.

How does the patented Healthy Glow Essentials Stack affect skin and cellular health?

The patent reports synergistic activation of cellular signaling genes linked to skin benefits and cellular stress reduction. According to the company, fibroblast studies showed joint effects that may support smoother skin, hydration, and broader cellular functions.

Which products are included in LifeVantage's patented Healthy Glow Essentials Stack (LFVN)?

The stack pairs Protandim Nrf2 Synergizer with TrueScience Liquid Collagen as the patented combination. According to the company, these activators support antioxidant production and collagen maintenance to target cellular aging pathways.

Does the LifeVantage patent change FDA approval or claims for LFVN products?

No; the patent does not equate to FDA approval or evaluation of product claims. According to the company, product statements have not been evaluated by the Food and Drug Administration and the disclaimer remains in place.

When did LifeVantage announce the patent grant for Healthy Glow Essentials Stack (LFVN)?

LifeVantage announced the patent grant on April 21, 2026, noting the U.S. patent was issued March 31, 2026. According to the company, the award follows more than three years of research and development.

What commercial or financial details did LifeVantage provide about the LFVN patent?

The announcement did not include revenue, licensing, or commercialization figures tied to the patent. According to the company, the release focused on the scientific patent grant and R&D validation rather than financial metrics.